Evidence for CYP2D6 expression in human lung

被引:43
作者
Lo Guidice, JM
Marez, D
Sabbagh, N
Legrand-Andreoletti, M
Spire, C
Alcaïde, E
Lafitte, JJ
Broly, F
机构
[1] Ctr Hosp Reg & Univ Lille, Hop Calmette, Lab Biochim & Biol Mol, F-59037 Lille, France
[2] Ctr Hosp Reg & Univ Lille, Hop Calmette, Clin Pneumophtisiol, F-59037 Lille, France
关键词
CYP2D6; expression; human lung; lung cancer; RT-PCR; immunochemistry;
D O I
10.1006/bbrc.1997.7775
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytochrome P450 CYP2D6 gene (CYP2D6) expression was examined in samples from human bronchial mucosa and lung parenchyma using reverse transcription-polymerase chain reaction (RT-PCR) and immunochemistry. Except specimen from a patient previously genotyped as homozygous for a complete deletion of the gene, all tissue samples were positive. When compared to that in the liver, the mean level of CYP2D6 mRNA was 3-fold lower in bronchial mucosa and 6-fold lower in lung parenchyma. To our knowledge, these data demonstrate for the first time the presence of CYP2D6 protein in human lung. They also indicate that the gene is nonuniformly distributed within this organ. The possibility that CYP2D6 has a role in lung carcinogenesis by locally activating inhaled chemicals should therefore be considered. (C) 1997 Academic Press.
引用
收藏
页码:79 / 85
页数:7
相关论文
共 30 条
[1]   Expression and localization of CYP3A4 and CYP3A5 in human lung [J].
Anttila, S ;
Hukkanen, J ;
Hakkola, J ;
Stjernvall, T ;
Beaune, P ;
Edwards, RJ ;
Boobis, AR ;
Pelkonen, O ;
Raunio, H .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (03) :242-249
[2]   LOCALIZATION, DISTRIBUTION, AND INDUCTION OF XENOBIOTIC-METABOLIZING ENZYMES AND ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY WITHIN LUNG [J].
BARON, J ;
VOIGT, JM .
PHARMACOLOGY & THERAPEUTICS, 1990, 47 (03) :419-445
[3]   GEOGRAPHICAL INTERRACIAL DIFFERENCES IN POLYMORPHIC DRUG OXIDATION - CURRENT STATE OF KNOWLEDGE OF CYTOCHROMES P450 (CYP) 2D6 AND 2C19 [J].
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1995, 29 (03) :192-209
[4]   METABOLISM AND ELIMINATION OF INHALED DRUGS AND AIRBORNE CHEMICALS FROM THE LUNGS [J].
BOND, JA .
PHARMACOLOGY & TOXICOLOGY, 1993, 72 :36-47
[5]  
Bouchardy C, 1996, CANCER RES, V56, P251
[6]   LUNG-CANCER AND CYP2D6 (THE DEBRISOQUINE POLYMORPHISM) - SOURCES OF HETEROGENEITY IN THE PROPOSED ASSOCIATION [J].
CAPORASO, N ;
DEBAUN, MR ;
ROTHMAN, N .
PHARMACOGENETICS, 1995, 5 :S129-S134
[7]   A TOBACCO SMOKE-DERIVED NITROSAMINE, 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, IS ACTIVATED BY MULTIPLE HUMAN CYTOCHROME P450S INCLUDING THE POLYMORPHIC HUMAN CYTOCHROME P4502D6 [J].
CRESPI, CL ;
PENMAN, BW ;
GELBOIN, HV ;
GONZALEZ, FJ .
CARCINOGENESIS, 1991, 12 (07) :1197-1201
[8]  
CZERWINSKI M, 1994, CANCER RES, V54, P1085
[9]  
DALY AK, 1995, J MOL MED-JMM, V73, P539
[10]   Nomenclature for human CYP2D6 alleles [J].
Daly, AK ;
Brockmoller, J ;
Broly, F ;
Eichelbaum, M ;
Evans, WE ;
Gonzalez, FJ ;
Huang, JD ;
Idle, JR ;
IngelmanSundberg, M ;
Ishizaki, T ;
JacqzAigrain, E ;
Meyer, UA ;
Nebert, DW ;
Steen, VM ;
Wolf, CR ;
Zanger, UM .
PHARMACOGENETICS, 1996, 6 (03) :193-201